Can Traditional CER Address Resource Allocation?

While the growth in U.S. healthcare costs is receiving substantial attention, many believe that instead of looking at general contributors, i.e. pharmaceutical pricing, we should look to resource allocation. Could Comparative Effectiveness Research (CER) methods help to answer this or is something different needed? Learn more here. (Source: Robert W Dubois, Future Medicine, Nov 2016)

You might also be interested in:

NPC's Dubois Talks Tradeoffs in Health Resource Allocation February 27, 2018
NPC’s Dubois Addresses Risk in Misinterpretation February 18, 2018
Dubois: Innovative Payment Solutions Required July 26, 2018
Dubois: ‘Why is drug spending so high?’ is Wrong Question March 13, 2018
NPC’s Dubois: Address U.S. Health Care Spending Now, Not Later December 8, 2017
NPC’s Dubois Talks Health Spending, Going Below the Surface September 17, 2018
Azar: Some in Pharma Mulling ‘Substantial’ Price Cuts June 12, 2018